NuvOx Pharma is a biotechnology company based in Tucson, Arizona developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
NuvOx's formulations are based on materials that deliver oxygen far more effectively than prior compounds, in particular, dodecafluoropentane emulsion (DDFPe). Pre-clinical data has shown efficacy in several indications including stroke, hypoxic solid tumors, sickle cell crisis, hemorrhagic shock, traumatic brain injury, and myocardial infarction. The company is in the clinical stage for oncology and stroke.
Painting by Diane Fairfield